Assisted Reproductive Technology (ART) Market to Reach USD 50.71 Billion by 2027 | Reports And Data

NEW YORK, June 3, 2020 /PRNewswire/ -- The global Assisted Reproductive Technology (ART) market is forecast to reach USD 50.71 Billion by 2027, according to a new report by Reports and Data. Assisted reproductive technology (ART) is the treatment for infertility in which laboratory fusion of ovule extracted from the women ovaries and are mixed with the male sperms is performed. There has been a dramatic rise in the number of women who have their babies at age 35 and over in the past four decades. This progression started in the mid-1970's in the U.S. and has proceeded to grow slowly over time. Fifteen percent of birth-giving people today are 35 and older, up from 11% in 2002 and 8% in 1990. Thus, with the increasing trends of late pregnancies across different parts of the world the adoption of ovulation test kits is anticipated to grow significantly.

Globally, approximately 0.3% of all infants born every year are conceived using assisted reproductive technology (ART) treatments. Moreover, growing awareness of ART and eliminated discomfort about pregnancy related disorders from social factors have contributed sufficient market boost of the ART procedures. According to the World Fertility Patterns statistics, Mexico's birth rates are about 2 kids per mother, well below the levels expected to support current Mexico's population. Brazil's birth rate is also smaller, at 1.75, close to that of 1.77 for Colombia. Costa Rica is also smaller, down from 1.66. These declining fertility rates can be threatening for woman and parents planning to conceive. Thus, more number of couples are approaching an artificial pregnancy method.

Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/1402 

A big market limiting factor is the stringent rules and regulations. The transfer of multiple embryos in a single cycle increases the rates of multiple births. Due to the increased social costs and health risks associated with multiple births, legislation or guidelines from professional societies have been introduced in many countries. Also, moderate success rate, which decreases the market demand, is expected to act as a restraining factor on the global market in the years ahead.

The COVID-19 impact:

The recent outbreak of COVID-19 has impacted growth of the market as in several countries the IVF or other ART procedures are being postponed or cancelled. Many studies have stated that women trying to conceive through ART are vulnerable to infection due to lower immunity. The restricted movements and extreme shutdown of the market in developed as well as developing nations has resulted into reduction of couples approaching ART. However, various gynecologist are maintaining the routine or follow up of surrogate or couples enlisted under ART procedures by using digital platform, hence after a short span of declination in the growth the market is estimated to grow in later phase of scenario.

Further key findings from the report suggest

• North America dominated the market with a revenue of USD 9.13 billion in 2019. In North America, the embryo/egg banking segment accounted for 2.17 billion market revenue in 2019 and is anticipated to grow USD 3.70 billion in 2027. This can be due to their changing lifestyle and increased adoption of late pregnancy.
• The segment of In-Vitro Fertilization (IVF) technology dominated the market. In 2019 the segment generated USD 21.68 billion in revenue. Access to government subsidized schemes and development of less cost intensive techniques of IVF is expected to drive the demand of ART in respective regions.
• Other emerging types of ART such as Gamete-Intra Fallopian Transfer (GIFT) and Zygote-Intra Fallopian Transfer (ZIFT) are anticipated to increase at a significant CAGR from 2019 to 2027
• The continuous growth in infertility is expected to create future opportunity revenue packets of the ART market.
• Key participants in the ART market are Merck KGaA (Germany), Cooper Surgical (Denmark), Fujifilm Irvine Scientific (US), Vitroife AB (Sweden), Thermo Fisher Scientific (US), Celmatix, Inc. (US), Anecova (Switzerland), OvaScience (US), Ferring Pharmaceuticals (US), , and FertiPro N.V. (Belgium).

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/assisted-reproductive-technology-art-market

For the purpose of this report, Reports and Data have segmented into the global Assisted Reproductive Technology market on the basis of procedure, technology, type, end use and region:

Procedures Outlook (Revenue, USD Billion; 2017-2027)

• Fresh Donor
• Fresh Non-Donor
• Frozen Donor
• Frozen Non-Donor
• Embryo/Egg Banking

Technology Outlook (Revenue, USD Billion; 2017-2027)

• In-Vitro Fertilization (IVF)
• IVF Using Intra-Cytoplasmic Sperm Injection (ICSI)
• IVF Without Using Intra-Cytoplasmic Sperm Injection (ICSI)
• Pre-Implantation Genetic Screening (PGS)
• Frozen Embryo Replacement (FER)
• Others

Type Outlook (Revenue, USD Billion; 2017-2027)

• Artificial Insemination
• Surrogacy
• Ovulation Induction
• Others

Order Now: https://www.reportsanddata.com/checkout-form/1402

End Use Outlook (Revenue, USD Billion; 2017-2027)

• Fertility Clinics
• Hospitals
• Clinical Research
• Others

Regional Outlook (Revenue, USD Billion; 2017-2027)

• North America
• U.S
• Europe
• U.K
• France
• Asia Pacific
• China
• India
• Japan
• MEA
• Latin America
• Brazil

Browse more similar reports on Diagnostics category by Reports And Data

• Influenza Diagnostics Market: https://www.reportsanddata.com/report-detail/influenza-diagnostics-market
• Infectious Disease Diagnostics Market: https://www.reportsanddata.com/report-detail/infectious-disease-diagnostics-market
• In-Vitro Diagnostics (IVD) Quality Control Market: https://www.reportsanddata.com/report-detail/in-vitro-diagnostics-ivd-quality-control-market

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com 
Direct Line: +1-212-710-1370  
E-mail: [email protected]
LinkedIn | Twitter | Blogs

SOURCE Reports And Data